Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ondansetron use for smoking cessation

C D Cropp1, M L Gora-Harper

  • 1Division of Pharmacy Practice, University of Kentucky Medical Center, Lexington 40536, USA.

The Annals of Pharmacotherapy
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation in drug transporters in ethnic populations.

Clinical pharmacology and therapeutics·2008
Same author

Opioid analgesics versus ketorolac in spine and joint procedures: impact on healthcare resources.

The Annals of pharmacotherapy·2001
Same author

Impact of antiemetic selection on postoperative nausea and vomiting and patient satisfaction.

Pharmacotherapy·2001
Same author

Development of a best-practice model at a university hospital to increase efficiency in the management of patients with community-acquired pneumonia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?

Clinical pharmacokinetics·1998
Same author

Validation of the Hartford nomogram in trauma surgery patients.

The Annals of pharmacotherapy·1998

Ondansetron, a medication studied for smoking cessation, did not show a significant benefit in a small trial. Larger studies are needed to confirm its effectiveness for quitting smoking.

Area of Science:

  • Pharmacology
  • Public Health
  • Clinical Trials

Background:

  • Cigarette smoking significantly impacts US health and healthcare costs.
  • Animal studies suggest ondansetron may reduce withdrawal symptoms, prompting interest in its use for smoking cessation.

Purpose of the Study:

  • To evaluate the efficacy of ondansetron as an aid for smoking cessation.
  • To address limitations of previous trials, including sample size and treatment duration.

Main Methods:

  • A small clinical trial investigated the effects of ondansetron on smoking behaviors.
  • Consideration of both oral and intravenous ondansetron formulations and their administration contexts.

Main Results:

  • The trial did not find evidence to support a beneficial effect of ondansetron in smoking cessation.

Related Experiment Videos

  • Limitations identified include small sample size and potentially insufficient therapy duration and follow-up.

    • Conclusions:

    • Current evidence does not support ondansetron's efficacy for smoking cessation.
    • Further large-scale, well-defined clinical studies are required to definitively assess ondansetron's role in smoking cessation.